Cite
HARVARD Citation
Mosca, A. et al. (2021). An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study. Japanese journal of clinical oncology. pp. 484-491. [Online].